{"id":2279,"date":"2023-05-13T02:30:09","date_gmt":"2023-05-13T02:30:09","guid":{"rendered":"https:\/\/magazines.uthscsa.edu\/cancer-center\/?p=2279"},"modified":"2023-05-19T07:55:45","modified_gmt":"2023-05-19T07:55:45","slug":"nih-grant-to-boost-ovarian-cancer-drug-development","status":"publish","type":"post","link":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/","title":{"rendered":"NIH grant to boost ovarian cancer drug development"},"content":{"rendered":"

The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health. It is the first grant of this kind awarded to UT Health San Antonio.<\/p>\n

The grant will be split between the two organizations. Mays Cancer Center will use $1.8 million to study the mechanism, safety and efficacy of EC359, a drug being studied as a stand-alone therapy as well as in combination with other drug treatments for ovarian cancer. Evestra will use $1.5 million for drug manufacturing, toxicity and formulation studies.<\/p>\n

According to the Centers for Disease Control and Prevention, treatment for ovarian cancer usually involves a combination of surgery and chemotherapy. For patients, the research and development of EC359 means a novel therapy drug can be used to curb the progression of ovarian cancer cells. Ovarian cancer ranks fifth in cancer deaths among women.<\/p>\n

\u201cReceiving support from the NIH will enhance and elevate our research in treating ovarian cancer,\u201d said Ratna K. Vadlamudi, PhD, professor and vice chair of research in the Department of Obstetrics and Gynecology at UT Health San Antonio.<\/p>\n

The NIH recently established the grant program to foster academic-industrial partnerships. This grant provides support for obtaining much-needed preclinical data before the drug is submitted for approval from the FDA to enter the first-in-human clinical trial phase.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.<\/p>\n","protected":false},"author":598,"featured_media":2339,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52],"magazine":[22],"issue-year":[49],"featured-story":[],"class_list":["post-2279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-therapies","magazine-cancer-center","issue-year-49"],"yoast_head":"\nNIH grant to boost ovarian cancer drug development - Mays Cancer Center Annual Report<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NIH grant to boost ovarian cancer drug development - Mays Cancer Center Annual Report\" \/>\n<meta property=\"og:description\" content=\"The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Mays Cancer Center Annual Report\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-13T02:30:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-19T07:55:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2023\/05\/NIH-Grant.png\" \/>\n\t<meta property=\"og:image:width\" content=\"763\" \/>\n\t<meta property=\"og:image:height\" content=\"834\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Karla Hignite\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karla Hignite\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/\"},\"author\":{\"name\":\"Karla Hignite\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#\\\/schema\\\/person\\\/6ce6ce71891598eb0173f0d285e7a66d\"},\"headline\":\"NIH grant to boost ovarian cancer drug development\",\"datePublished\":\"2023-05-13T02:30:09+00:00\",\"dateModified\":\"2023-05-19T07:55:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/\"},\"wordCount\":236,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2023\\\/05\\\/NIH-Grant.png\",\"articleSection\":[\"New Therapies\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/\",\"name\":\"NIH grant to boost ovarian cancer drug development - Mays Cancer Center Annual Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2023\\\/05\\\/NIH-Grant.png\",\"datePublished\":\"2023-05-13T02:30:09+00:00\",\"dateModified\":\"2023-05-19T07:55:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#\\\/schema\\\/person\\\/6ce6ce71891598eb0173f0d285e7a66d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2023\\\/05\\\/NIH-Grant.png\",\"contentUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2023\\\/05\\\/NIH-Grant.png\",\"width\":763,\"height\":834,\"caption\":\"UT Health San Antonio researchers conduct biopharmaceutical studies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/2023\\\/05\\\/13\\\/nih-grant-to-boost-ovarian-cancer-drug-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mays Cancer Center Annual Report\",\"item\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/magazine\\\/cancer-center\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"NIH grant to boost ovarian cancer drug development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#website\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/\",\"name\":\"Mays Cancer Center Annual Report\",\"description\":\"Mays Cancer Center Annual Reports\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/#\\\/schema\\\/person\\\/6ce6ce71891598eb0173f0d285e7a66d\",\"name\":\"Karla Hignite\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1262fab3104fb7ec5678a5af8a40505f00dc05d47624676e2454cfe489013d98?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1262fab3104fb7ec5678a5af8a40505f00dc05d47624676e2454cfe489013d98?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1262fab3104fb7ec5678a5af8a40505f00dc05d47624676e2454cfe489013d98?s=96&d=mm&r=g\",\"caption\":\"Karla Hignite\"},\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/cancer-center\\\/author\\\/hignite\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NIH grant to boost ovarian cancer drug development - Mays Cancer Center Annual Report","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"NIH grant to boost ovarian cancer drug development - Mays Cancer Center Annual Report","og_description":"The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.","og_url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/","og_site_name":"Mays Cancer Center Annual Report","article_published_time":"2023-05-13T02:30:09+00:00","article_modified_time":"2023-05-19T07:55:45+00:00","og_image":[{"width":763,"height":834,"url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2023\/05\/NIH-Grant.png","type":"image\/png"}],"author":"Karla Hignite","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karla Hignite","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#article","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/"},"author":{"name":"Karla Hignite","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#\/schema\/person\/6ce6ce71891598eb0173f0d285e7a66d"},"headline":"NIH grant to boost ovarian cancer drug development","datePublished":"2023-05-13T02:30:09+00:00","dateModified":"2023-05-19T07:55:45+00:00","mainEntityOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/"},"wordCount":236,"commentCount":0,"image":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2023\/05\/NIH-Grant.png","articleSection":["New Therapies"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/","name":"NIH grant to boost ovarian cancer drug development - Mays Cancer Center Annual Report","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#website"},"primaryImageOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2023\/05\/NIH-Grant.png","datePublished":"2023-05-13T02:30:09+00:00","dateModified":"2023-05-19T07:55:45+00:00","author":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#\/schema\/person\/6ce6ce71891598eb0173f0d285e7a66d"},"breadcrumb":{"@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#primaryimage","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2023\/05\/NIH-Grant.png","contentUrl":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-content\/uploads\/sites\/12\/2023\/05\/NIH-Grant.png","width":763,"height":834,"caption":"UT Health San Antonio researchers conduct biopharmaceutical studies"},{"@type":"BreadcrumbList","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/2023\/05\/13\/nih-grant-to-boost-ovarian-cancer-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/magazines.uthscsa.edu\/cancer-center\/"},{"@type":"ListItem","position":2,"name":"Mays Cancer Center Annual Report","item":"https:\/\/magazines.uthscsa.edu\/cancer-center\/magazine\/cancer-center\/"},{"@type":"ListItem","position":3,"name":"NIH grant to boost ovarian cancer drug development"}]},{"@type":"WebSite","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#website","url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/","name":"Mays Cancer Center Annual Report","description":"Mays Cancer Center Annual Reports","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/magazines.uthscsa.edu\/cancer-center\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/magazines.uthscsa.edu\/cancer-center\/#\/schema\/person\/6ce6ce71891598eb0173f0d285e7a66d","name":"Karla Hignite","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1262fab3104fb7ec5678a5af8a40505f00dc05d47624676e2454cfe489013d98?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1262fab3104fb7ec5678a5af8a40505f00dc05d47624676e2454cfe489013d98?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1262fab3104fb7ec5678a5af8a40505f00dc05d47624676e2454cfe489013d98?s=96&d=mm&r=g","caption":"Karla Hignite"},"url":"https:\/\/magazines.uthscsa.edu\/cancer-center\/author\/hignite\/"}]}},"_links":{"self":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/posts\/2279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/users\/598"}],"replies":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/comments?post=2279"}],"version-history":[{"count":0,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/posts\/2279\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/media\/2339"}],"wp:attachment":[{"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/media?parent=2279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/categories?post=2279"},{"taxonomy":"magazine","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/magazine?post=2279"},{"taxonomy":"issue-year","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/issue-year?post=2279"},{"taxonomy":"featured-story","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/cancer-center\/wp-json\/wp\/v2\/featured-story?post=2279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}